跳转至内容
Merck
CN

AB136

多巴脱羧酶抗体

Chemicon®, from rabbit

登录 查看组织和合同定价。

选择尺寸


关于此项目

UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
Conjugate:
unconjugated
Clone:
polyclonal
Application:
WB
Citations:
16
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

biological source

rabbit

conjugate

unconjugated

antibody form

affinity isolated antibody

antibody product type

primary antibodies

clone

polyclonal

purified by

affinity chromatography

species reactivity

canine, sheep, human

manufacturer/tradename

Chemicon®

technique(s)

western blot: suitable

NCBI accession no.

UniProt accession no.

shipped in

wet ice

target post-translational modification

unmodified

Quality Level

Gene Information

human ... DDC(1644)

Immunogen

来自人DDC的N端区域的KLH偶联合成肽。

Application

免疫印迹:1:1000

最佳工作稀释度必须由最终用户进行确定。
多巴脱羧酶抗体是一种针对多巴脱羧酶的抗体,可用于WB。
研究子类别
神经递质 & 受体

神经元 & 胶质标记
研究类别
神经科学

Biochem/physiol Actions

DOPA多巴脱羧酶(DDC)。通过蛋白质印迹法与约55 kDa的单条带反应。与人类样本反应最佳;对啮齿动物和兔的反应性较低。

Physical form

亲和纯化的抗体。 在10 mM HEPES(pH 7.5),150 mM NaCl,100 μg/mL BSA和50%甘油中的液体。

Preparation Note

自收到之日起,在-20至-80°C以未稀释的等分试样可保存6个月。存放在非自除霜的冰箱中。应避免反复冻融循环。

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

除非我们的产品目录或产品附带的其他公司文档另有说明,否则我们的产品仅供研究使用,不得用于任何其他目的,包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。

未找到合适的产品?  

试试我们的产品选型工具.

存储类别

10 - Combustible liquids

wgk

WGK 1


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Thamara E Osinga et al.
Neuroendocrinology, 101(4), 289-295 (2015-02-14)
Increased dopamine production may be a feature of head and neck paraganglioma (HNPGL). 18F-fluorodihydroxyphenylalanine positron emission tomography scintigraphy has a high sensitivity for detecting HNPGLs. These observations strongly suggest that HNPGLs have the capacity for L-3,4-dihydroxyphenylalanine uptake and conversion towards
Mohammad M Doroudchi et al.
Journal of neurochemistry, 93(3), 634-640 (2005-04-20)
Although L-DOPA is the drug of choice for Parkinson's disease, prolonged L-DOPA therapy results in decreased drug effectiveness and the appearance of motor complications. This may be due in part to the progressive loss of the enzyme, aromatic L-amino acid
Intrarenal dopamine modulates progressive angiotensin II-mediated renal injury.
Yang, S; Yao, B; Zhou, Y; Yin, H; Zhang, MZ; Harris, RC
American Journal of Physiology: Renal Physiology null
SAFETY AND TOLERABILITY OF MRI-GUIDED INFUSION OF AAV2-hAADC INTO THE MID-BRAIN OF NON-HUMAN PRIMATE.
San Sebastian, W; Kells, AP; Bringas, J; Samaranch, L; Hadaczek, P; Ciesielska et al.
Molecular therapy. Methods & clinical development null
Cerebral infusion of AAV9 vector-encoding non-self proteins can elicit cell-mediated immune responses.
Ciesielska, A; Hadaczek, P; Mittermeyer, G; Zhou, S; Wright, JF; Bankiewicz, KS; Forsayeth, J
Molecular Therapy null

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持